ApoGlyx
www.apoglyx.comApoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).
Read more
Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).
Read more
Country
City (Headquarters)
Lund
Industry
Employees
1-10
Founded
2015
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Non Executive Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(13)
Reach decision makers at ApoGlyx
Free credits every month!
ApoGlyx FAQ
Lund, Sweden
Biotechnology Research
We'll help you understand if Lusha can solve your business needs.
